IP Library › Granted Patent US 9,199,973
Granted Patent B2
US 9,199,973 · App. 14/536,896 · Granted Dec 1, 2015

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,199,973
App. No.
14/536,896
Granted
Dec 1, 2015
Kind
B2
Abstract

A pharmaceutical formulation comprising the compound of formula

Claims (6)

1. A method of treating breast cancer by administering a pharmaceutical formulation presented in unit dose form comprising the compound of formula

as an active ingredient,

wherein said active ingredient is present within said unit dose form in an amount from 0.5 mg to 1 g.

2. The method of claim 1 , wherein the pharmaceutical formulation is administered as a single dose per day.

3. The method of claim 1 , wherein the pharmaceutical formulation is administered as a number of sub-doses per day.

4. The method of claim 1 , wherein said unit dose is a tablet.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2015
From: LEO OSPREY LIMITED
To: NOVARTIS AG
Reel/Frame 035771/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2015
From: GLAXOSMITHKLINE LLC
To: LEO OSPREY LIMITED
Reel/Frame 035762/0741 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2015
From: CARTER, MALCOLM CLIVE; COCKERILL, GEORGE STUART; LACKEY, KAREN ELIZABETH
To: GLAXOSMITHKLINE LLC
Reel/Frame 034696/0362 →